Eli Lilly and Company
F.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patients
The disease can vary in severity, but for some, it can be life-altering — a total loss of body hair, including eyelashes and eyebrows, even nose hair and hair in the ears. And, until recently, for those with alopecia areata, there was no treatment to make the hair grow back. But on Monday, the Food […]
Know More
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
An experimental drug has enabled people with obesity or who are overweight to lose about 22.5 percent of their body weight, about 52 pounds on average, in a large trial, the drug’s maker announced on Thursday. The company, Eli Lilly, has not yet submitted the data for publication in a peer-reviewed medical journal or presented […]
Know More
FDA Panel Rejects Lilly’s Cancer Drug Tested Only in China
The agency has long had strict rules about approving drugs that were tested solely overseas, requiring that the data be applicable to patients and medical practice in the United States, that the investigators had “recognized competence” and that the agency be able to validate the data. In a withering critique of Lilly’s submission on this […]
Know More